Working with an international consortium conducting research on breast, ovarian and prostate cancer among 200,000 people, Professor Jacques Simard, researcher at the CHU de Québec Research Centre and holder of the Canada Research Chair in Oncogenetics at Université Laval, was actively involved in the discovery of DNA “spelling mistakes” linked to breast cancer. These mistakes – known as genetic variations – are directly involved in the risk of developing breast cancer.

Canadians with debilitating diseases will soon benefit from new personalized approaches to treatment thanks to researchers across the country and funding from the Harper Government. The Honourable Gary Goodyear, Minister of State (Science and Technology), today announced the results of a major $150-million genomics and personalized health competition, a Genome Canada—Canadian Institutes of Health Research (CIHR) partnership.